High Serum Soluble CD30 Does Not Predict Acute Rejection in Liver Transplant Patients

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3601-3604

  Matinlauri, I ^a   Hockerstedt K ^a   Isoniemi, H ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD30 ANTIGEN; CYCLOSPORIN A; HLA ANTIBODY; HLA ANTIGEN CLASS 1; METHYLPREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NEEDLE BIOPSY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ACUTE DISEASE; ANTIGENS, CD30; BIOLOGICAL MARKERS; GRAFT REJECTION; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; REOPERATION; REPRODUCIBILITY OF RESULTS;

EID: 33845419188     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.063     Document Type: Article

References (16)

1. Schwab U., Stein H., Gerdes J., et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299 (1982) 65
2. Stein H., Mason D.Y., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 (1985) 848
3. Del Prete G., De Carli M., Almerigogna F., et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 9 (1995) 81
4. Romagnani S., Del Prete G., Maggi E., et al. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 57 (1995) 726
5. Muta H., Boise L.H., Fang L., et al. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol 165 (2000) 5105
6. Pelzl S., Opelz G., Wiesel M., et al. Soluble CD30 as a predictor of kidney graft outcome. Transplantation 73 (2002) 3
7. Süsal C., Pelzl S., Döhler B., et al. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 13 (2002) 1650
8. Pelzl S., Opelz G., Daniel V., et al. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 75 (2003) 421
9. Matinlauri I.H., Kyllönen L.E.J., Salmela K.T., et al. Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations. Transplantation 80 (2005) 1809
10. Bauwens A.M., Van de Graaf E.A., Van Ginkel W.G.J., et al. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 25 (2006) 416
11. Frisaldi E., Conca P., Magistroni P., et al. Prognostic values of soluble CD30 and CD30 gene polymorphism in heart transplantation. Transplantation 81 (2006) 1153
12. Matinlauri I.H., Höckerstedt K.K.A., and Isoniemi H.M. Equal overall rejection rate in pre-transplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation. Clin Transplant 19 (2005) 626
13. Rajakariar R., Jivanji N., Varagunam M., et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 5 (2005) 1922
14. Süsal C., Pelzl S., and Opelz G. Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 76 (2003) 1231
15. Krams S.M., Cao S., Hayashi M., et al. Elevations in IFN-γ, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 80 (1996) 311
16. De Lazzari F., Ravagnan P., Tenderini M.L., et al. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease. Hepato-Gastroenterology 49 (2002) 231